Research Establishment Fellowships

2022 recipients

Dr Elizabeth AhernDr Elizabeth Ahern
RACP Research Establishment Fellowship ($50,000)
‘PREMONITION: PREcision Medicine study Of Non-small cell lung cancer (NSCLC) Immunotherapy Tumour microenvironment (TME) adaptatION’

Dr Ahern is a Medical Oncologist working at Monash Health practicing in early phase trials, CNS, lung and cutaneous cancers and melanoma. She was awarded a Postdoctoral Fellowship for 2021 from the School of Medicine, Monash University to continue research in immunology of cancer. Her PhD, awarded from University of Queensland in January 2021, was in preclinical immunology and immune-oncology research at Queensland Institute of Medical Research assessing a novel role for the tumour necrosis family member RANKL as a partner in combinational immunotherapy. 

She is stream lead for neuro-oncology and lung cancer clinical trials at Monash Health. She is a principal investigator on a investigator-initiated trials of neoadjuvant immunotherapy in lung cancer and immune correlates of COVID-19 vaccination in Australian children and adults with cancer. Dr Ahern is an adjunct senior lecturer at the School of Medicine, Monash University and a Visiting Scientist at the Queensland Institute of Medical Research.

Dr Jasna AleksovaDr Jasna Aleksova
RACP Diabetes Australia Research Establishment Fellowship ($50,000)
‘Fracture prediction using DXA-derived cortical parameters compared with high-resolution peripheral quantitative CT (HR-pQCT) in patients with end stage kidney disease and type 1 diabetes mellitus’

Dr Jasna Aleksova is an endocrinologist and clinician researcher with her primary interests in metabolic bone disorders and osteoporosis. She completed her PhD with an NHMRC grant examining the role of novel risk factors and imaging tools to improve fracture prediction in patients with chronic kidney disease and renal transplantation. She continues her research interests in CKD as a research fellow at Monash University and adjunct fellow at the Hudson Institute through competitive grants and fellowships and has been the recipient of numerous national and international awards including the ASBMR young investigator award. 

She has been on the editorial board for the ESA’s primary journal Clinical Endocrinology and was the inaugural clinical representative of the ANZBMS Early Career Investigator Committee. As a practising endocrinologist she works in the metabolic bone clinics at Monash Health and St Vincent’s Health, convening her clinical and research endeavours.

Dr Miles AndrewsDr Miles Andrews
The Robert Maple-Brown Research Establishment Fellowship ($60,000)
‘Liquid biopsy of microRNAs as biomarkers and targets for immunotherapy in skin and thoracic cancers’

Dr Andrews is a Consultant Medical Oncologist at The Alfred, and Early Career Research Fellow at Monash University. He has clinical sub-specialty interests in the management of patients with cancers of the skin, chest, and head & neck. After gaining specialist qualifications in Medical Oncology in 2012, Dr Andrews completed a PhD in genomics and melanoma biology at the Olivia Newton-John Cancer Research Institute and University of Melbourne, followed by a three-year postdoctoral fellowship at the University of Texas MD Anderson Cancer Center focused primarily on multi-platform biomarker studies of cancer immunotherapy and targeted therapy.

He leads several clinical and biospecimen-driven translational research projects evaluating the fundamental biology of cancer therapies, and identification of clinically useful biomarkers to guide treatment decisions. He has particular expertise in cancer immunobiology, the cancer microbiome, and neoadjuvant clinical trials in melanoma, having published in these fields in journals such as Science, Nature Medicine, Cell, Lancet Oncology, and PNAS. Dr Andrews is also clinical lead for melanoma registry projects through the Personalised Oncology Division at WEHI. He is actively involved in cancer clinical trials at The Alfred, and is engaged with supervision/mentoring of trainees.

Dr Philip BrittonDr Philip Britton
Cottrell Research Establishment Fellowship ($75,000)
‘Emerging Infectious Diseases in Children: Surveillance that Informs Action’

Dr Britton is a paediatrician and infectious diseases physician at the Children’s Hospital at Westmead, and a senior lecturer in child and adolescent health with the University of Sydney. He is an early career clinician researcher with expertise in surveillance of severe childhood infectious disease especially neurological infections. He co-leads the Paediatric Active Enhanced Disease Surveillance (PAEDS) network for which he is a lead investigator for surveillance of childhood encephalitis, Acute Flaccid Paralysis and from 2020 COVID-19 and its multi-system inflammatory complications in children. Dr Britton's work spans the detection, clinical care, laboratory investigation of and public health response to severe childhood infectious diseases. 

Dr Jessica DayDr Jessica Day
RACP Australian Rheumatology Association & D.E.V Starr Research Establishment Fellowship ($50,000)
‘Initiatives to facilitate early diagnosis and prevent disability in myositis’

Dr Jessica Day is a rheumatologist and clinician-scientist who completed her doctorate on myositis at the Royal Adelaide Hospital. The quality of her PhD research has been recognised by the conferral of eleven awards, scholarships and/or grants between 2016 and 2020. This includes the 2020 Ian Davey Thesis Prize, awarded to the most outstanding PhD thesis by a University of South Australia Higher Degree Research Student. Dr Day is currently undertaking post-doctoral studies on myositis at the Walter and Eliza Hall Institute, runs a dedicated myositis clinic at the Royal Melbourne Hospital and attends a monthly muscle biopsy list at St Vincent’s Hospital Melbourne. Her aim is to set up a translational myositis research program which focuses on preventing disability in patients with inflammatory muscle diseases.

Associate Professor Sunita De SousaA/Prof Sunita De Sousa
RACP Fellows Research Establishment Fellowship ($75,000)
‘Utility of a Maturity Onset Diabetes of the Young (MODY) probability calculator and exome sequencing to diagnose monogenic diabetes in the Australian clinic setting’

Associate Professor Sunita De Sousa is a consultant endocrinologist at the Royal Adelaide Hospital and the South Australian Adult Genetics Unit. Her PhD on the genetics and clinical aspects of prolactinomas was awarded the University of Adelaide Doctoral Research Medal. She has also completed an MSc at the University of London and fellowships in pituitary endocrinology at St Vincent’s Hospital in Sydney and endocrine genetics in the South Australian Clinical Genetics Service.

Sunita is an active member of the Endocrine Society of Australia, currently serving as the Clinical Chair of the ESA Early Career Committee. The main theme of her postdoctoral studies is monogenic diabetes, drawing upon her clinical experience in running the South Australian Endocrine Genetics Clinic. She is also the clinical genetics lead for the Royal Adelaide Hospital’s total pancreatectomy and islet autotransplantation clinical and research service for hereditary pancreatitis, and she was a co-author of the recent Australian position statement on the assessment and management of primary hyperparathyroidism.

Dr Vikas GoyalDr Vikas Goyal
RACP Research Establishment Fellowship ($50,000)
‘Improving the management of pulmonary exacerbations for paediatric bronchiectasis’

Vikas is a Paediatric Respiratory and Sleep Physician, currently a clinician researcher at Queensland Children’s Hospital and Gold Coast University Hospital. His NHMRC supported PhD “Advancing the knowledge, understanding and management of respiratory exacerbations of bronchiectasis in children” has been awarded Dean's award for excellence in research. The research studies from his PhD were the world’s first ones to prove the usefulness of oral antibiotics in children with bronchiectasis exacerbations. His studies have been incorporated into guidelines nationally and internationally. He has academic, clinical and research roles and is actively involved in the college including being a member of the Queensland Regional Committee.

Dr Gwo Yaw HoDr Gwo Yaw Ho
RACP Research Establishment Fellowship ($50,000)
‘An iMOP for iTARGETs: An integrated Multi-Omics Platform for identifying immunogenic TARGETs’

Dr Gwo Yaw Ho is a senior medical oncologist and a clinician-scientist investigating better ways to treat ovarian cancer. Dr Ho graduated from The University of Glasgow, Scotland, in 2004, before completing his medical oncology specialist training in Brisbane, Queensland, in 2014. He has completed laboratory-based translational PhD at Walter and Eliza Hall Institute of Medical Research, Melbourne in ovarian and rare cancer research whilst undertaking a role of a medical oncologist at Peter McCallum Cancer Centre and Royal Women’s Hospital, Melbourne.

Dr Ho is now a part of the medical oncology team at Monash Health treating patients with breast and gynaecologic cancer. He also has a role as a trialist at the Clinical Trial Unit, Monash. His research project focuses on harnessing and redirecting the patients' immune system to eliminate cancer cells in hardest-to-treat ovarian cancer. The ultimate goal is to develop personalised cell-based immunotherapy targeting cancer-specific mutant peptides.

Dr Stephanie JohnsonDr Stephanie Johnson
RACP Endocrine Society of Australia Research Establishment Fellowship in Endocrinology ($50,000)
‘IPAD - Insulin Pumps At Diagnosis’

Dr Johnson is a paediatric endocrinologist at the Queensland Children's Hospital and has a long standing interest in paediatric diabetes research and diabetes technology in particular, having published on insulin pump outcomes and more recently on the national continuous glucose monitoring (CGM) roll out. She completed her PhD in massively parallel sequencing for monogenic diabetes and hypersinulinism, and identified a potential new diabetes gene. She has established a collaboration with researchers at Kings College London and Vanderbilt University Tennessee to explore the functional effect of this gene.

She is currently a co-PI for the Australasian Diabetes Database Network, a collaboration between the Australasian Paediatric Endocrine Group, the Australian Diabetes Society, the JDRF Australia Clinical Research Network, the University of Melbourne, and the many diabetes centres represented by the ADDN Study Group. She is currently the ADDN representative on an international diabetes database collaboration and is on the CGM subcommittee, reporting on the outcomes of the national CGM rollout.

Dr Ayano KellyDr Ayano Kelly
The Sir Roy McCaughey Research Establishment Fellowship ($75,000)
‘Implementation of a pharmacy-led medication adherence clinic for gout’

Ayano Kelly is a Rheumatologist and early career researcher with a strong interest in person-centred research and implementation and evaluation of interventions to support medication adherence. She graduated from the University of New South Wales with Honours and completed Basic Physician Training at Liverpool Hospital and Rheumatology Advanced Training at John Hunter Hospital and the Canberra Hospital. Her PhD at the Australian National University awarded in 2020 is titled “Identifying and addressing patient-centred outcomes to improve medication adherence in rheumatology”.

She is a Senior Lecturer at the South Western Clinical School at UNSW and chair of the Outcome Measures in Rheumatology – Medication Adherence (OMERACT-Adherence) Special Interest Group. The group aims to develop a core set of outcomes to be used in all trials testing medication adherence interventions in Rheumatology. Outside of work and research, she enjoys fostering cats, baking and painting.

Dr Tracy LeongDr Tracy Leong
RACP Research Establishment Fellowship ($50,000)
‘Profiling B cells in metastatic lung cancer’

Dr Tracy Leong is a Respiratory clinician-scientist-researcher with specific interests in the fields of interventional pulmonology and translational lung cancer research. She completed her PhD through the University of Melbourne in 2018 and was awarded the David Bickart Clinical Researcher Fellowship in 2019 to continue her post-doctoral work at the Walter and Eliza Hall Institute of Medical Research. She leads a multi-institute collaboration of lung cancer clinicians, scientists, and consumers whose shared aim is to overcome treatment resistance in lung cancer.

Dr Kylee MaclachlanDr Kylee Maclachlan
The Robert Maple-Brown Research Establishment Fellowship ($60,000)
‘Defining genomic and immune risk factors for progression in multiple myeloma precursor disease’

Dr Kylee Maclachlan is a Haematologist and Clinician Researcher. She attended the Otago University Medical School in Aotearoa New Zealand, attained her General Physician qualification through St Vincent’s Hospital in Melbourne, and her Haematology Specialist qualifications through Monash Health and Alfred Health. In 2019 she completed a PhD through the University of Melbourne and the Peter MacCallum Cancer Centre investigating novel drug combinations for the cancer multiple myeloma.

Subsequently, Dr Maclachlan commenced a Visiting Investigator position at the Memorial Sloan Kettering Cancer Centre in New York, based in the Myeloma Genomics Group. Her current research aims to improve the prognostication of multiple myeloma and precursor conditions by integrating genomic information into clinical decision-making.

Dr Avik MajumdarDr Avik Majumdar
RACP Research Establishment Fellowship ($50,000)
‘Exploring the pathogenesis of cirrhotic cardiomyopathy with metabolomic profiling’

Avik Majumdar is a transplant hepatologist at Austin Health and Clinical Associate Professor at The University of Melbourne. After completing his gastroenterology advanced training in 2014, he spent 2 years at the Royal Free Hospital, London as a senior fellow and then locum consultant in hepatology and liver transplantation. In 2017, he was appointed as a staff specialist at the Australian National Liver Transplant Unit and AW Morrow Gastroenterology and Liver Centre at Royal Prince Alfred Hospital, Sydney, where he maintains an honorary position, before returning to Melbourne in 2022.

Avik was awarded his PhD in 2018 in risk stratification in cirrhosis and portal hypertension. His main research focus has been non-invasive biomarkers and prognostication in advanced liver disease, portal hypertension and liver transplantation. He established the RPA Liver Biobank in 2018 for this purpose and has several active national and international research collaborations, as well as supervises higher degree research students. He has published in peak journals in his field and his research has been cited in international clinical guidelines. Avik has been an executive member of the GESA-Liver Faculty since 2019, NSW Transplant Advisory Committee from 2017-2022 and has been involved in national clinical guideline development.

Dr Amali MallawaarachchiDr Amali Mallawaarachchi
The Jacquot Research Establishment Fellowship ($90,000)
‘Investigating mechanisms of disease in Autosomal Dominant Polycystic Kidney Disease through combining established Clinical Cohorts and Cellular Genomic Technologies’

Dr Mallawaarachchi is a Clinician-Scientist with a research focus in polycystic kidney disease and in the genetics of inherited kidney disease. She is a Clinical Geneticist and Nephrologist, and Staff Specialist at Royal Prince Alfred Hospital, Sydney. Dr Mallawaarachchi is also a Senior Research Scientist in the Division of Genomics and Epigenetics at the Garvan Institute of Medical Research, Sydney. She has particular expertise in genomic analysis and developed the first validated whole-genome sequencing based genetic testing for polycystic kidney disease. This translated into Australia’s first diagnostic test for these conditions.

Her current research targets understanding the molecular pathogenesis of polycystic kidney disease. She also has a research focus in applying genomic technologies to improve diagnostics for kidney disease. Her research translates into the clinic, where she is the NSW State Lead of the KidGen Collaborative and leads a multidisciplinary renal genetics clinic. She also has international expertise in variant and gene curation in genetic kidney disease as an invited expert in developing variant and gene curation practice guidelines.

Dr Hugh McCarthyDr Hugh McCarthy
The Jacquot Research Establishment Fellowships ($90,000)
‘The UNICORN study: UNravelling the Immune mechanisms contributing to ChildhOod steroid Resistant Nephrotic syndrome’

Dr Hugh McCarthy (PhD FRCPCH FRACP) is a full time paediatric nephrologist and clinical researcher within the University Of Sydney and Sydney Children’s Hospitals Network. Hugh established and runs the NSW paediatric renal genetic clinical service. His research focuses on the care of children living with rare and genetic renal disease and the study of the pathogenesis of nephrotic syndrome both genetic and immune mediated. Hugh developed the UK National Registry of Rare Renal Disease (RADAR) as part of his PhD; he is developing the equivalent in Australia - Australian Registry of Rare and Genetic Kidney Disease ( to provide a trial ready platform for national cohort build and provide an informatic hub for families. His research spans the study of the psychosocial burden of genetic testing in the renal clinic to laboratory based analysis of the molecular pathways of immune mediated nephrotic syndrome together with the identification of novel genes associated with inherited kidney disease.

Associate Professor Chrishan NalliahA/Prof Chrishan Nalliah
RACP Research Establishment Fellowship ($50,000)
‘Atrial fibrillation associates with impaired atrial microvascular function and cardiac energetics’

Dr Nalliah is appointed Conjoint Associate Professor at Macquarie University/Macquarie University Hospital and NHF post-doctoral fellow and was recently appointed pacing and electrophysiology lead at Bankstown-Lidcombe Hospital. Dr Nalliah was awarded a PhD in 2020, supported by the NHMRC/NHF co-funded scholarship evaluating novel mechanisms of atrial fibrillation (AF). His research was awarded the Ralph Reader Prize 2020, Heart Rhythm Society Eric Prystowsky prize 2020 and Asia Pacific Heart Rhythm Society (APHRS) Young Investigator of the Year 2017. His work's quality and relevance were acknowledged by award of the William Parmley Prize 2021 by the American College of Cardiology.

Dr Nalliah has authored 60 publications, is an invited speaker at CSANZ and an invited panelist at the APHRS meeting. In addition to the present project, Dr Nalliah leads studies evaluating the mechanisms of AF and therapies to facilitate management/cure. His vision is to integrate the highest levels of clinical care with novel and cutting-edge research, to deliver world class arrhythmia care.

Dr Felix NgDr Felix Ng
RACP Foundation for High Blood Pressure Research Establishment Fellowship ($50,000)
‘Cerebral no-reflow phenomenon in stroke as a factor and potential therapeutic target in reperfusion treatment failure’

Dr Felix Ng is a stroke neurologist and postdoctoral research fellow at the Royal Melbourne Hospital. He also serves as a stroke neurologist at Austin Health, the Victoria Stroke Telemedicine service and on the Melbourne Mobile Stroke Unit – Australia’s first custom-built ambulance vehicle equipped with an onboard CT-scanner. He is the co-investigator in the Bridging the Urban and regional Divide in Stroke care (BUILDS) initiative that aims to establish tele-Stroke Units in regional Victoria and is an executive committee member of the Stroke Society of Australasia Emerging Stroke Clinician and Scientist Special Interest Group. His research interests include stroke reperfusion treatment and complications and improving stroke service delivery and system of care. His PhD focused on neuroimaging abnormalities post-treatment with an emphasis on cerebral edema and microvascular dysfunction. He aims to expand his findings on post-reperfusion pathophysiology in his postdoctoral research.

Dr Claire OwenDr Claire Owen
RACP Research Establishment Fellowship ($50,000)
‘Prospective Validation of 18F-FDG Whole Body PET/CT as a Diagnostic Test for Polymyalgia Rheumatica’

Dr Claire Owen is an early career clinician-researcher employed as a consultant rheumatologist at Austin Health, who graduated with a Doctor of Philosophy from the University of Melbourne in January, 2021. Since 2014, Claire has worked hard to establish a research agenda in polymyalgia rheumatica (PMR) in Australia, a common but notoriously understudied inflammatory rheumatic disease. Her thesis entitled “Predictors of relapse in PMR patients treated with low-dose glucocorticoid therapy” characterized the demographic, clinical, laboratory and imaging phenotype of patients with a relapsing disease course. Results of this work additionally informed a proof-of-concept PET/MRI fusion study confirming peritendonitis as a pathologic hallmark of PMR and provided the basis for the development of a novel scoring algorithm for diagnosing PMR on whole body PET/CT with high sensitivity and specificity.

Since 2017, Claire has also been an active contributor to the PMR Working Group of OMERACT, an international collaboration of clinicians, researchers and patient partners committed to improving outcome measures in rheumatology. In 2019, Claire accepted the position of PMR Working Group Co-Chair and is currently jointly responsible for overseeing the development of a core outcome measurement set for use in all future clinical research involving patients with PMR.

Dr Sagun ParakhDr Sagun Parakh
The Servier Staff 'Barry Young' Research Establishment Fellowship ($50,000)
‘Improving responses to immunotherapy in Non-small cell lung cancer’

I am a Medical Oncologist, specialising in lung cancer and primary brain tumours at the Austin Hospital in Melbourne and am jointly appointed to the Olivia Newton-John Cancer Research Institute (ONJCRI) as a research fellow. After obtaining my fellowship in 2014, I completed my PhD focusing on the development of a novel first-in-class anti-ErbB2 antibody targeting conformation epitopes. I am principal investigator on numerous clinical trials in lung cancer, primary brain tumours as well as for early phase clinical trials. I remain committed to laboratory research and continue my research as a clinician-scientist in the Tumor Targeting Laboratory at the ONJCRI. 

My current research which is supported by a Victorian Cancer Agency ECR Fellowship focuses on investigating novel therapies in lung cancer. As a clinician dealing with cancer patients, I know the challenges faced by patients and families, and the impact of successful therapies on their lives. Through my research into identifying and developing new treatments I hope to make a difference in improving outcomes for cancer patients.

Dr Peter SavasDr Peter Savas
RACP GSK Research Establishment Fellowship ($50,000)
‘Interrogating the immune microenvironment to improve breast cancer treatment’

Dr Peter Savas is a medical oncologist and clinician scientist specialising in breast cancer at the Peter MacCallum Cancer Centre, Royal Melbourne Hospital and the University of Melbourne. His work uses new technologies to understand more about how the characteristics of a breast cancer and the microenvironment around it contribute to disease and influence therapy. With this understanding he hopes to improve how we diagnose breast cancer, develop markers which can guide therapy and ultimately develop new therapies. He obtained his PhD at the Peter MacCallum Cancer Centre/University of Melbourne in 2020. During his PhD he developed a precision oncology program which has recruited over 400 patients with advanced breast cancer. His work has also included applying genomics to illuminate cancer evolution and heterogeneity in advanced disease, and pioneering the use of single cell technology to investigate tumour infiltrating immune cells. He is principal investigator on several clinical trials in advanced breast cancer and an international steering committee member.

Dr Brendan SmythDr Brendan Smyth
The Jacquot Research Establishment Fellowship ($90,000)
‘Launching SEISMIC and growing RESOLVE: two platforms for improving symptom management and cardiovascular outcomes in kidney failure’

Dr Smyth is a nephrologist based in Sydney, Australia. He graduated from the University of Sydney in 2008 and trained in nephrology. He completed his PhD in 2020, investigating randomized controlled trial methods and implementation in haemodialysis. His interests are in improving dialysis care, symptom management, and increasing participation in randomized research in nephrology.

He has lead the development of the International Society of Nephrology(ISN) Clinical Trials Toolkit and Global Trials Focus and he is an ISN Emerging Leader for 2022. He has 34 publications and has contributed textbook chapters, been an associate editor of the journal Kidney Blood Pressure Research, and continues to teach university students and junior doctors. He now works as a post-doctoral fellow at the NHRMC Clinical Trials Centre, University of Sydney, and is a Staff Specialist Nephrologist at St George Hospital, Sydney.

Dr Chau Thien TayDr Chau Thien Tay
The Roger Bartop Research Establishment Fellowship ($60,000)
‘The effect of combined oral contraceptive pills on the development of type 2 diabetes and dyslipidaemia in women with and without polycystic ovary syndrome’

Dr Chau Thien (Jillian) Tay is an endocrinologist and clinical academic. After obtaining her medical degree at the University of Tasmania, she completed her RACP Basic and Advanced Physician Training in Endocrinology rotating though Flinders Medical Centre, Lyell McEwin Hospital and Monash Health. Jillian attained her PhD from Monash University in 2021 and has since then continued to pursue her research interest in polycystic ovary syndrome. Jillian has received several prestigious awards including the Outstanding Abstract Awards from the Endocrine Society Annual Meeting in 2020 and the AHRA Women's Health Research and Translation Network Early and Mid-Career Researcher Funded Award in 2021.

She also holds several leadership roles including the Chair of the international Androgen Excess and Polycystic Ovary Syndrome Society (AEPCOS) Early Career Special Interest Group, Chair of the national Centre of Research Excellence in Women's Health in Reproductive Life (CRE WHiRL) Early to Mid-Career Researcher Collective, Co-editor of the AEPCOS newsletter and a member of the CRE WHiRL's Training and Mentoring Committee. Jillian currently leads several epidemiological research projects using data from the Australian Longitudinal Study on Women's Health. She hopes to unravel the natural history of polycystic ovary syndrome using longitudinal population-based cohort studies.

Dr James WhittleDr James Whittle
RACP Research Establishment Fellowship ($50,000)
‘Circulating tumour DNA as a non-invasive biomarker of recurrence in low grade gliomas’

Dr James (Jim) Whittle is a clinician scientist focused on glioma biology and translational brain cancer research. He is a medical oncologist, specialising in Neuro Oncology at the Peter MacCallum Cancer Centre and joint laboratory head, Brain Cancer Research Laboratory, Personalised Oncology Division, WEHI. Jim qualified in medicine at the University of Western Australia, and subsequently undertook specialty training in Melbourne at the Royal Melbourne Hospital, Peter MacCallum Cancer Centre, and Box Hill Hospital. 

He completed his PhD at WEHI in the Visvader/Lindeman laboratory and received the “Professor Lynn Corcoran PhD Prize” for his research understanding the molecular mechanisms that are responsible for resistance to cell death in breast cancer. This work has provided the foundation for testing novel compounds in early phase clinical trials, together with industry collaboration. Following his PhD, Jim commenced working remotely with the Ligon laboratory, Dana Faber Cancer Institute, with a focus on uncovering resistance mechanisms to glioma and in 2021, was appointed joint laboratory head at WEHI, establishing the Brain Cancer Research Laboratory, together with Dr Sarah Best and Dr Saskia Freytag.

Dr Limy WongDr Limy Wong
The Jacquot Research Establishment Fellowship ($90,000)
‘Establishing co-culture systems to study the crosstalk between bone, muscle and adipose tissues in chronic kidney disease’

Dr Limy Wong is a nephrologist and postdoctoral research fellow at Eastern Health and Adjunct Senior Lecturer at Monash University in Melbourne. She graduated with First Class Honours in medicine from the Royal College of Surgeons in Ireland and completed specialist training in Ireland and the UK, including a clinical Fellowship in Transplant Nephrology at Beaumont Hospital, the Irish National Renal Transplant Centre.

Following this, she was awarded a prestigious Wellcome Trust Clinical PhD Fellowship to work in Professor Ken Smith’s laboratory at the University of Cambridge, studying the genetics of ANCA-associated vasculitis and was awarded a PhD in Medicine in 2020. She subsequently relocated to Melbourne to take up her current position and continues to harness her previous research experience to explore the emerging area of sarcopenia in chronic kidney disease. Her research work is centred around understanding the molecular basis of sarcopenia and the biochemical interactions between muscle and bone tissues, to identify more effective means to improve musculoskeletal health in the chronic kidney disease population.

Past recipients
Research Establishment Fellowships

Back to award recipients

Close overlay